3 weeks ago
Medicamen Biotech Board Recommends Rs 1 Final Dividend for FY26
Medicamen Biotech board recommends a final dividend of Rs 1 per equity share for FY26, pending shareholder approval at the upcoming Annual General Meeting.
Continue Reading